Rechercher | Vivos👋

Tejas Kudale Ajouter une nouvelle offre d'emploi Autre
2026-08-26 07:32:58 -

Asthma Drugs Market Expansion at 3.98% CAGR Driven by Innovative Inhaled Therapies
Asthma drugs in the biologic category—such as omalizumab, mepolizumab, and dupilumab—target specific immune components driving severe, uncontrolled eosinophilic or allergic asthma. Administered via subcutaneous injection, these monoclonal antibodies neutralize specific IgE antibodies, interleukin-5 (IL-5), or interleukin-4/13 pathways. Biologics significantly reduce reliance on...

0 Commentaires 0 Parts 16 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Tejas Kudale Ajouter une nouvelle offre d'emploi Autre
2026-06-03 09:42:23 -

Asthma Drugs Market Expected to Achieve US$ 40.04 Billion Valuation by 2033
Asthma drugs are pharmaceutical treatments designed to prevent, control, and relieve symptoms of asthma by reducing airway inflammation and improving breathing function in patients. The Asthma Drugs Market size is expected to reach US$ 40.04 Billion by 2033 from US$ 29.3 Billion in 2025. The market is estimated to record a CAGR of 3.98% from 2026 to 2033. The steady rise in...

0 Commentaires 0 Parts 315 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Tejas Kudale Ajouter une nouvelle offre d'emploi Autre
2026-08-12 09:30:03 -

Expanding Access to Respiratory Care Drives the Asthma Drugs Market to US$ 40.04 Billion by 2033
Asthma drugs are medications designed to prevent, control, and relieve asthma symptoms by reducing airway inflammation and improving breathing. The Asthma Drugs Market share is expected to reach US$ 40.04 Billion by 2033 from US$ 29.3 Billion in 2025. The market is estimated to record a CAGR of 3.98% from 2026 to 2033. The increasing prevalence of asthma, growing awareness...

0 Commentaires 0 Parts 103 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Tejas Kudale Ajouter une nouvelle offre d'emploi Autre
2026-07-09 10:26:11 -

Increasing Investments in Respiratory Drug Development to Accelerate Market Growth by 2033
Asthma drugs are medications designed to prevent, control, and relieve asthma symptoms by reducing airway inflammation, relaxing bronchial muscles, and improving breathing. The Asthma Drugs Market size is expected to reach US$ 40.04 Billion by 2033 from US$ 29.3 Billion in 2025. The market is estimated to record a CAGR of 3.98% from 2026 to 2033. The rising prevalence of...

0 Commentaires 0 Parts 218 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!